Questions: Lymphocyte Development Checkpoints and Selection

Question 1

A developing T cell successfully rearranges its TCRβ gene and pairs the resulting chain with the pre-Tα surrogate chain to form the pre-TCR. What does this pre-TCR checkpoint test, and what happens to cells that fail it?

• A. It tests whether the cell can recognize self-MHC; cells that fail are positively selected and eliminated
• B. It tests whether V(D)J recombination produced a functional TCRβ chain; cells with non-productive rearrangements (frameshifts or stop codons) die by apoptosis
• C. It tests whether the cell has eliminated its self-reactive tendencies; cells that bind self-peptide strongly proceed to the double-positive stage
• D. It tests whether CD4 or CD8 coreceptors are properly expressed; cells without coreceptors cannot form the pre-TCR

Answer: (B)

Beta-selection is the first major T cell developmental checkpoint. V(D)J recombination is a stochastic process — many rearrangements introduce frameshifts or stop codons that prevent a functional protein. The pre-TCR checkpoint verifies that recombination produced a functional TCRβ chain before the cell invests in further development. Cells with non-productive rearrangements cannot form a pre-TCR, receive no survival signals, and die by apoptosis. Cells that pass the checkpoint proliferate and progress to the double-positive stage. This is the first of three sequential tests for T cells — the later two (positive and negative selection) test MHC recognition and self-tolerance.

Question 2

A student trying to remember T cell checkpoints confuses positive and negative selection. Which statement correctly describes what each checkpoint eliminates?

• A. Positive selection eliminates cells that bind self-peptide–MHC too strongly (dangerous self-reactives); negative selection eliminates cells that fail to recognize any self-MHC (useless cells)
• B. Positive selection eliminates cells that fail to recognize self-MHC at all (they die by neglect); negative selection eliminates cells that bind self-peptide–MHC too strongly (to prevent autoimmunity)
• C. Positive selection occurs in the bone marrow; negative selection occurs in the thymus cortex
• D. Both checkpoints eliminate the same cells — those lacking CD4 or CD8 coreceptors

Answer: (B)

The names are counterintuitive for students. Positive selection 'positively selects' for cells that can recognize self-MHC at all — cells that fail to bind any self-MHC receive no survival signal and die by neglect. This ensures every mature T cell carries a receptor that can interact with the MHC molecules it will encounter in the body. Negative selection then eliminates cells whose TCR binds self-peptide–MHC too strongly — these would attack the body's own tissues. Confusing the two is extremely common; remember: positive selection keeps cells that 'see' MHC; negative selection kills cells that 'see' self too well.

Question 3

Positive selection in the thymus eliminates T cells that bind self-MHC too strongly, since these would be dangerous self-reactive cells.

• T. True
• F. False

Answer: False

This describes negative selection, not positive selection. Positive selection eliminates cells that fail to bind self-MHC at all — they die by neglect because they receive no survival signal. The logic is that a T cell incapable of recognizing any MHC molecule would be useless in the periphery (T cells present antigens in the context of MHC). Cells that DO bind self-MHC survive positive selection and progress to negative selection, which then tests whether the binding is too strong — dangerous high-affinity self-reactivity triggers deletion. The two checkpoints work in sequence: first ensure the receptor works (positive), then ensure it's not autoreactive (negative).

Question 4

A defect in the negative selection checkpoint during T cell development would be more likely to predispose an individual to autoimmunity than to immunodeficiency.

• T. True
• F. False

Answer: True

Negative selection eliminates T cells with high-affinity self-reactivity. When negative selection fails, self-reactive cells escape to the periphery where they can attack the body's own tissues — the hallmark of autoimmunity. By contrast, defects in β-selection or positive selection eliminate too few cells at those checkpoints (paradoxically causing later problems if useless cells survive) or eliminate too many (causing immunodeficiency by depleting the functional repertoire). The checkpoint logic is clear: negative selection's specific job is central tolerance, so its failure specifically undermines self-tolerance.

Question 5

Why do the lymphocyte development checkpoints produce such extreme cell death (95–99% of developing lymphocytes), and what two goals does this massive attrition serve?

Model answer: The attrition is not wasteful — it is the mechanism by which the immune system simultaneously ensures functional competence and central tolerance. The first goal is functional competence: checkpoints verify that each lymphocyte carries a receptor that actually works (recognizes MHC for T cells, can signal through a surface BCR for B cells). Cells with non-productive gene rearrangements are eliminated before they waste resources. The second goal is central tolerance: checkpoints eliminate cells whose receptors would attack the body's own tissues. The two goals together explain the 95–99% attrition — most cells either fail to make a functional receptor or make one that is self-reactive, and both must be removed.

This dual-purpose logic is the key insight of the topic. Immunodeficiency results when checkpoints are too stringent or fail to produce enough functional cells. Autoimmunity results when checkpoints (especially negative selection) fail to eliminate self-reactive cells. The enormous attrition rate is not pathological — it is the normal price of producing a repertoire that is diverse, functional, and non-self-reactive. Viewing it as waste misses the point.